3-hydroxyephedrine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohnen, NI; Frey, KA; Gilman, S; Koeppe, RA; Raffel, DM; Wong, KK | 1 |
| Berding, G; Dengler, R; Knapp, WH; Kolbe, H; Meyer, GJ; Peschel, T; Schrader, CH; van den Hoff, J | 1 |
1 trial(s) available for 3-hydroxyephedrine and Parkinson Disease
| Article | Year |
|---|---|
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophy.
Topics: Carbon Radioisotopes; Diagnosis, Differential; Ephedrine; Feasibility Studies; Heart; Humans; Liver; Metabolic Clearance Rate; Multiple System Atrophy; Myocardium; Organ Specificity; Parkinson Disease; Pilot Projects; Radiopharmaceuticals; Tomography, Emission-Computed; Vagus Nerve | 2003 |
1 other study(ies) available for 3-hydroxyephedrine and Parkinson Disease
| Article | Year |
|---|---|
Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.
Topics: Aged; Carbon Radioisotopes; Case-Control Studies; Contrast Media; Ephedrine; Female; Heart; Heart Conduction System; Heart Ventricles; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prospective Studies; Sympathetic Nervous System | 2012 |